Hepatoma-derived growth factor is induced in liver regeneration

Hepatology Research

Volumn 39, Issue 10, 2009, Pages 988-997

  Enomoto, Hirayuki ^a   Nakamura, Hideji ^a   Liu, Weidong ^a   Yoshida, Kenya ^b   Okuda, Yorihide ^b   Imanishi, Hiroyasu ^a   Saito, Masaki ^a   Shimomura, Soji ^a   Hada, Toshikazu ^c   Nishiguchi, Shuhei ^a  

^a Department of Internal Medicine   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

Hepatocyte; Hepatoma derived growth factor; Liver; Regeneration

Indexed keywords

CARBON TETRACHLORIDE; COMPLEMENTARY DNA; DNA; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEPATOMA DERIVED GROWTH FACTOR; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DNA SYNTHESIS; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER PARENCHYMA; LIVER REGENERATION; LIVER RESECTION; MOUSE; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 73849125692     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00532.x     Document Type: Article

References (49)

1. Nakamura H, Kambe H, Egawa T, et al. Partial purification and characterization of human hepatoma-derived growth factor. Clin Chim Acta 1989; 183: 273-84.
2. Nakamura H, Izumoto Y, Kambe H et al. Molecular cloning of complementary DNA for a novel human hepatoma-derived growth factor. Its homology with high mobility group-1 protein. J Biol Chem 1994; 269: 25143-9.
3. Oliver JA, Al-Awqati Q. An endothelial growth factor involved in rat renal development. J Clin Invest 1998; 102: 1208-19.
4. Everett AD, Lobe DR, Matsumura ME, Nakamura H, McNamara CA. Hepatoma-derived growth factor stimulates smooth muscle cell growth and is expressed in vascular development. J Clin Invest 2000; 105: 567-75.
5. Kishima Y, Yoshida K, Enomoto H et al. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells. Hepatogastroenterology 2002; 49: 1639-44.
6. Izumoto Y, Kuroda T, Harada H, Kishimoto T, Nakamura H. Hepatoma-derived growth factor belongs to a gene family in mice showing significant homology in the amino terminus. Biochem Biophys Res Commun 1997; 238: 26-32.
7. Ikegame K, Yamamoto M, Kishima Y et al. A new member of a hepatoma-derived growth factor gene family can translocate to the nucleus. Biochem Biophys Res Commun 1999; 266: 81-7.
8. Dietz F, Franken S, Yoshida K, Nakamura H, Kappler J, Gieselmann V. The family of hepatoma-derived growth factor proteins: characterization of a new member HRP-4 and classification of its subfamilies. Biochem J 2002; 366: 491-500.
9. Ge H, Si Y, Roeder RG. Isolation of cDNAs encoding novel transcription coactivators p52 and p75 reveals an alternate regulatory mechanism of transcriptional activation. EMBO J 1998; 17: 6723-9.
10. Singh DP, Ohguro N, Chylack LT Jr, Shinohara T. Lens epithelium-derived growth factor: increased resistance to thermal and oxidative stresses. Invest Ophthalmol Vis Sci 1999; 40: 1444-51.
11. Okuda Y, Nakamura H, Yoshida K et al. Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor. Cancer Sci 2003; 94: 1034-41.
12. Yoshida K, Nakamura H, Okuda Y et al. Expression of hepatoma-derived growth factor in hepatocarcinogenesis. J Gastroenterol Hepatol 2003; 18: 1293-301.
13. Zhang J, Ren H, Yuan P et al. Down-regulation of hepatoma-derived growth factor inhibits anchorage independent growth and invasion of non-small cell lung cancer cells. Cancer Res 2006; 66: 18-23.
14. Yoshida K, Tomita Y, Okuda Y et al. Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma. Ann Surg Oncol 2006; 13: 159-67.
15. Hu TH, Huang CC, Liu LF et al. Expression of hepatomaderived growth factor in hepatocellular carcinoma. Cancer 2003; 98: 1444-56.
16. Yamamoto S, Tomita Y, Hoshida Y et al. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. Clin Cancer Res 2006; 12: 117-22.
17. Ren H, Tang X, Lee JJ et al. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. J Clin Oncol 2004; 22: 3230-7.
18. Uyama H, Tomita Y, Nakamura H et al. Hepatoma-derived growth factor is a novel prognostic factor for patients with pancreatic cancer. Clin Cancer Res 2006; 12: 6043-8.
19. Chang KC, Tai MH, Lin JW et al. Hepatoma-derived growth factor is a novel prognostic factor for gastrointestinal stromal tumors. Int J Cancer 2007; 121: 1059-65.
20. Yamamoto S, Tomita Y, Hoshida Y et al. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma. Ann Surg Oncol 2007; 14: 2141-9.
21. Enomoto H, Yoshida K, Kishima Y et al. Hepatoma-derived growth factor is highly expressed in developing liver and promotes fetal hepatocyte proliferation. Hepatology 2002; 36: 1519-27.
22. Higgins GM, Anderson RM. Arch. Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal. Arch Pathol 1931; 12: 186-202.
23. Kinoshita T, Tashiro K, Nakamura T. Marked increase of HGF mRNA in non-parenchymal liver cells of rats treated with hepatotoxins. Biochem Biophys Res Commun 1989; 165: 1229-34.
24. Michalopoulos GK, DeFrances MC. Liver regeneration. Science 1997; 276: 60-6.
25. Taub R, Greenbaum LE, Peng Y. Transcriptional regulatory signals define cytokine-dependent and-independent pathways in liver regeneration. Semin Liver Dis 1999; 19: 117-27.
26. Fausto N. Mouse liver tumorigenesis: models, mechanisms, and relevance to human disease. Semin Liver Dis 1999; 19: 243-52.
27. Kishima Y, Yamamoto H, Izumoto Y et al. Hepatomaderived growth factor stimulates cell growth after translocation to the nucleus by nuclear localization signals. J Biol Chem 2002; 277: 10315-22.
28. Evarts RP, Nakatsukasa H, Marsden ER, Hu Z, Thorgeirsson SS. Expression of transforming growth factor-alpha in regenerating liver and during hepatic differentiation. Mol Carcinog 1992; 5: 25-31.
29. Webber EM, FitzGerald MJ, Brown PI, Bartlett MH, Fausto N. Transforming growth factor-alpha expression during liver regeneration after partial hepatectomy and toxic injury, and potential interactions between transforming growth factor-alpha and hepatocyte growth factor. Hepatology 1993; 18: 1422-31.
30. Kiso S, Kawata S, Tamura S et al. Role of heparin-binding epidermal growth factor-like growth factor as a hepatotrophic factor in rat liver regeneration after partial hepatectomy. Hepatology 1995; 22: 1584-90.
31. Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991; 13: 743-50.
32. Kiso S, Kawata S, Tamura S et al. Expression of heparinbinding EGF-like growth factor in rat liver injured by carbon tetrachloride or D-galactosamine. Biochem Biophys Res Commun 1996; 220: 285-8.
33. Skov Olsen P, Boesby S, Kirkegaard P et al. Influence of epidermal growth factor on liver regeneration after partial hepatectomy in rats. Hepatology 1988; 8: 992-6.
34. Gohda E, Tsubouchi H, Nakayama H et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988; 81: 414-19.
35. Nakamura T, Nishizawa T, Hagiya M et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989; 342: 440-3.
36. Marsden ER, Hu Z, Fujio K, Nakatsukasa H, Thorgeirsson SS, Evarts RP. Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab Invest 1992; 67: 427-33.
37. Baruch Y, Shoshany G, Neufeld G, Enat R. Basic fibroblast growth factor is hepatotropic for rat liver in regeneration. J Hepatol 1995; 23: 328-32.
38. Mochida S, Ishikawa K, Inao M, Shibuya M, Fujiwara K. Increased expressions of vascular endothelial growth factor and its receptors, flt-1 and KDR/flk-1, in regenerating rat liver. Biochem Biophys Res Commun 1996; 226: 176-9.
39. Fausto N. Liver regeneration. J Hepatol 2000; 32 (Suppl. 1): 19-31.
40. Okada M, Sakairi T, Kusakabe M et al. Immunohistochemical localization of transforming growth factor Alpha in regenerating Rat Liver. J Vet Med Sci 2002; 64: 1045-8.
41. Sakuda S, Tamura S, Yamada A et al. NF-kappaB activation in non-parenchymal liver cells after partial hepatectomy in rats: possible involvement in expression of heparinbinding epidermal growth factor-like growth factor. J Hepatol 2002; 36: 527-33.
42. Uehara Y, Minowa O, Mori C et al. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995; 373: 702-5.
43. Schmidt C, Bladt F, Goedecke S et al. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995; 373: 699-702.
44. Hilberg F, Aguzzi A, Howells N, Wagner EF. c-jun is essential for normal mouse development and hepatogenesis. Nature 1993; 365: 179-81.
45. Beg AA, Sha WC, Bronson RT, Ghosh S, Baltimore D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B. Nature 1995; 376: 167-70.
46. Cilley RE, Zgleszewski SE, Chinoy MR. Fetal lung development: airway pressure enhances the expression of developmental genes. J Pediatr Surg 2000; 35: 113-18.
47. Gallitzendoerfer R, Abouzied MM, Hartmann D, Dobrowolski R, Gieselmann V, Franken S. Hepatoma-derived growth factor (HDGF) is dispensable for normal mouse development. Dev Dyn 2008; 237: 1875-85.
48. Cressman DE, Greenbaum LE, DeAngelis RA et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996; 274: 1379-83.
49. Yamamoto T, Nakamura H, Liu W et al. Involvement of hepatoma-derived growth factor in the growth inhibition of hepatocellular carcinoma cells by vitamin K2. J Gastroenterol 2009; 44: 228-35.